Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06613022 · ClinicalTrials.gov registry record · NA
Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Grip Strength
A NA study, sponsored by Beth Marschner.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT06613022: Completed NA study, sponsored by Beth Marschner.
NCT06613022 is a NA study that has completed, run by Beth Marschner. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06613022, a NA study, has completed, sponsored by Beth Marschner.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy adult volunteers. The main questions it aims to answer are: * Does IASTM treatment have an effect on range of motion (ROM) as measured in the elbow, wrist and thumb? * Does IASTM treatment have an effect on grip strength? Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change ROM and/or grip strength. Participants will: * Complete a questionnaire on medical history and injury background * Have elbow, wrist, and thumb range of motion (ROM) measurements taken on both upper extremities using a goniometer * Undergo grip strength testing using a JAMAR hand dynamometer in three positions on both upper extremities * Be randomly assigned to either IASTM first treatment group or the wait/control first group * Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the forearm wrist flexors and wrist extensors and the biceps and triceps using the HG8-Scanner tool and then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) in each direction for a total treatment time of 20 minutes for both upper extremities in all listed areas. * Simply wait for 20 minutes (the duration of time treatment with IASTM would require) when assigned to the control group. * Complete elbow, wrist and thumb range of motion and grip strength measurement testing at the end of the first session. * Return within fourteen days after the first session in order to undergo the opposite experience (IASTM first means wait/control second and vice versa). * Undergo the same baseline pre-test measurements for range of motion and grip strength as the first session. * Experien
Interventions
- OTHER Instrument Assisted Soft Tissue Mobilization first Control second
- OTHER Control first Instrument Assisted Soft Tissue Mobilization second
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2024-01-08 |
| Est. Completion | 2024-02-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06613022
The ClinicalTrials.gov registry entry for NCT06613022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Marschner, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Instrument Assisted Soft Tissue Mobilization first Control second is the first listed.
NCT06613022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06613022 about?
NCT06613022 is a clinical study titled "Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Grip Strength". The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy adult volunteers. The main questions it aims to answer are: * Does IASTM treatment have an effect on range of motion (ROM) as measured in the elbow, wrist and thumb? * Does IAS...
What is the current status of trial NCT06613022?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2024-01-08. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT06613022?
The interventions under investigation include: Instrument Assisted Soft Tissue Mobilization first Control second (OTHER), Control first Instrument Assisted Soft Tissue Mobilization second (OTHER).
Who is sponsoring clinical trial NCT06613022?
This trial is sponsored by Beth Marschner, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.